Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT05304091

Characterization of Rhythmicity Profiles of Bradykinin-mediated Angioedema Attacks Using a Tracking Smartphone Application.

Rhythmicity Profiles of Bradykinin-mediated Angioedema.

Status
Withdrawn
Phase
Study type
Observational
Enrollment
0 (actual)
Sponsor
University Hospital, Lille · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Bradykinin-mediated angioedema is a rare and disabling disease, characterized by the occurrence of attacks marked by localized swelling of skin, but also of the airways, which can be life-threatening. The unpredictable nature of attacks is a key feature of angioedema, placing patients under constant threat. It seems that there are different patterns of yearly distribution for these attacks, but this is poorly described in the literature. The objectives of the study are to establish different rhythmicity profiles of patients according to the frequency of the attacks; and to identify factors potentially triggering the attacks. For this purpose, patients with bradykinin-mediated angioedema will be monitored daily using a smartphone application. Each day, the application will ask the patient if he or she is having an attack and, if so, the characteristics of the attack and the events preceding it

Conditions

Interventions

TypeNameDescription
OTHERQuestionnaire on a smartphone applicationEach day, the smartphone application will ask the patient if he or she is having an angioedema attack. It not, the questionnaire will stop. If the patient is having an attack, a series of 5 short questions is asked about the attack characteristics and the events that preceded it.

Timeline

Start date
2022-08-01
Primary completion
2023-08-01
Completion
2023-08-01
First posted
2022-03-31
Last updated
2025-12-26

Source: ClinicalTrials.gov record NCT05304091. Inclusion in this directory is not an endorsement.